Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
STAT+
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Health Tech
STAT+

AI developers battle with FDA, what’s next with Amazon and One Medical, & protecting wearables data

  • Lizzy Lawrence

By Lizzy Lawrence Feb. 23, 2023

Reprints
FDA stop sign
Sarah Silbiger/Getty Images

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. 

Industry fumes as FDA increases AI tool regulation

advertisement

Health tech companies are in a tizzy. After years of letting companies roll out software tools to guide patient care with little oversight, the Food and Drug Administration is taking a tougher stance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Lizzy Lawrence

Lizzy Lawrence

Medical Devices Reporter

Lizzy Lawrence is a medical devices reporter at STAT.

Tags

Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.

How Tennessee is creating new opportunities for doctors trained…
How Tennessee is creating new opportunities for doctors trained outside the U.S.
23andMe had devastating news about my health. I wish…
23andMe had devastating news about my health. I wish a person had delivered it
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Neuralink can now study its brain implant in humans,…
Neuralink can now study its brain implant in humans, but it’s still catching up to its…
Omada tackles obesity drugs, Boston Scientific nixes deal, and…
Omada tackles obesity drugs, Boston Scientific nixes deal, and Microsoft health exec on GPT
Listen: ChatGPT in medicine, a boom in weight loss…
Listen: ChatGPT in medicine, a boom in weight loss pills, & Sarepta at the FDA

Recommended Stories